The National Engineering Laboratory for Anti-Tumor Protein Therapeutics, Tsinghua University, Beijing, China.
Beijing Key Laboratory for Protein Therapeutics, Tsinghua University, Beijing, China.
Oncogene. 2018 Mar;37(11):1519-1533. doi: 10.1038/s41388-017-0062-6. Epub 2018 Jan 12.
As a rate-limiting step in metastasis, metastatic colonization requires survival signals from supportive stroma. However, the mechanisms driving this process are incompletely understood. Here, we showed that the proliferation of B16F10 cells was promoted when cocultured with lung fibroblasts. Meanwhile, co-injection of B16F10 tumor cells with mouse lung fibroblasts significantly increased lung metastasis. Based on GEO database, we identified stearoyl-CoA desaturase 1 (SCD1) as a novel factor promoting metastatic colonization. Importantly, we found that fibroblast-secreted cathepsin B (CTSB) induced the upregulation of SCD1 in B16F10 through Annexin A2 (ANXA2) and PI3K/Akt/mTOR pathway. The elevated SCD1 induced a higher ratio of monounsaturated fatty acids to saturated fatty acids in B16F10 cells. The changes in fatty acid composition contributed to tumor cell proliferation and metastatic colonization. Furthermore, targeting SCD1 effectively inhibited lung metastasis and prolonged the overall survival of mice. Meanwhile, the expression of SCD1 was negatively correlated with disease-free survival in five types of cancer patients. Collectively, our study identifies SCD1 as a critical modulator of tumor cell proliferation that is activated by cathepsin B, secreted by lung fibroblasts at the metastatic niche. Our novel findings provide potential therapeutic targets to prevent tumor metastasis.
作为转移的限速步骤,转移性定植需要来自支持性基质的存活信号。然而,驱动这一过程的机制尚不完全清楚。在这里,我们表明,当与肺成纤维细胞共培养时,B16F10 细胞的增殖得到促进。同时,B16F10 肿瘤细胞与小鼠肺成纤维细胞的共同注射显著增加了肺转移。基于 GEO 数据库,我们确定硬脂酰辅酶 A 去饱和酶 1(SCD1)是促进转移性定植的新因子。重要的是,我们发现成纤维细胞分泌的组织蛋白酶 B(CTSB)通过膜联蛋白 A2(ANXA2)和 PI3K/Akt/mTOR 通路诱导 B16F10 中 SCD1 的上调。升高的 SCD1 诱导 B16F10 细胞中不饱和脂肪酸与饱和脂肪酸的比例升高。脂肪酸组成的变化有助于肿瘤细胞的增殖和转移定植。此外,靶向 SCD1 可有效抑制肺转移并延长小鼠的总生存期。同时,SCD1 的表达与五种癌症患者的无病生存期呈负相关。总之,我们的研究确定 SCD1 是肿瘤细胞增殖的关键调节剂,它被肺成纤维细胞在转移部位分泌的组织蛋白酶 B 激活。我们的新发现为预防肿瘤转移提供了潜在的治疗靶点。